Search Results for: name
ALG2 Gene Glycosylation Disorder Type 1I Genetic Test Cost
The ALG2 Gene Glycosylation Disorder Type 1I Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the ALG2 gene, which can lead to a rare condition known as Congenital Disorders of Glycosylation Type 1I (CDG-1I). This condition is part of a group of inherited metabolic disorders that affect the process of glycosylation—the attachment of sugar molecules to proteins and lipids, which is crucial for their proper function. Mutations in the ALG2 gene disrupt this process, leading to a wide range of symptoms, including developmental delay, neurological issues, and digestive problems. The test, priced at 4400 AED, involves collecting a DNA sample, usually through a blood draw, and analyzing it for specific genetic mutations associated with the disorder. It is particularly recommended for individuals with clinical symptoms of CDG-1I or those with a family history of the condition. Early and accurate diagnosis through the ALG2 Gene Glycosylation Disorder Type 1I Genetic Test can be critical for the management and treatment of the condition, allowing for tailored therapies and interventions that can significantly improve the quality of life for affected individuals. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures a reliable and efficient testing process, offering crucial insights into this complex genetic disorder.
DPAGT1 Gene Glycosylation Disorder Type 1J Genetic Test Cost
The DPAGT1 gene glycosylation disorder Type 1J genetic test is a specialized diagnostic procedure designed to identify mutations in the DPAGT1 gene, which are associated with Congenital Disorders of Glycosylation (CDG). Type 1J CDG is a rare genetic condition that affects the normal process of adding sugar chains to proteins, a critical process for proper protein function. Symptoms of the disorder can vary widely among individuals but may include developmental delay, neurological issues, and problems with the digestive system, among others. This genetic test involves analyzing the patient's DNA to look for specific mutations in the DPAGT1 gene that are known to cause the disorder. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals. The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the DPAGT1 gene glycosylation disorder Type 1J genetic test at DNA Labs UAE is 4400 AED. This price may cover the collection of the sample, the genetic analysis, and the provision of a detailed report explaining the results. Patients interested in undergoing this test are advised to consult with a healthcare provider or a genetic counselor to understand the implications of the test results and explore potential treatment options.
ALG1 Gene Glycosylation Disorder Type 1K Genetic Test Cost
The ALG1 Gene Glycosylation Disorder Type 1K Genetic Test is a specialized diagnostic tool used to identify mutations in the ALG1 gene, which are associated with Congenital Disorders of Glycosylation Type 1k (CDG-1k). These disorders are a group of rare genetic conditions that affect the normal process of glycosylation, the addition of sugar chains to proteins and lipids, which is essential for proper cellular function. Individuals with CDG-1k may present with a variety of symptoms, including developmental delay, intellectual disability, liver dysfunction, and coagulation abnormalities. Performed at DNA Labs UAE, this genetic test involves analyzing the patient's DNA to detect mutations in the ALG1 gene, providing crucial information for accurate diagnosis and management of the condition. The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. This test is vital for families seeking answers to complex genetic conditions and offers a pathway towards personalized care and management strategies for affected individuals.
ALG9 Gene Glycosylation Disorder Type 1L Genetic Test Cost
The ALG9 Gene Glycosylation Disorder Type 1L Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the ALG9 gene, which can lead to Congenital Disorders of Glycosylation (CDG). CDG Type 1L is a rare genetic condition that affects the body's ability to properly glycosylate proteins and lipids, essential processes for normal cellular function. Symptoms of the disorder can vary but often include developmental delay, liver dysfunction, coagulation abnormalities, and neurological issues. This test is particularly important for individuals showing symptoms suggestive of CDG Type 1L or for families with a history of the condition, as early detection can significantly influence management and treatment options. The test involves analyzing the patient's DNA to identify mutations in the ALG9 gene, which are responsible for the disorder. At DNA Labs UAE, the test is priced at 4400 AED, reflecting the comprehensive analysis and the specialized expertise required to interpret the results. Conducting the test in a reputable facility like DNA Labs UAE ensures accuracy and reliability, providing crucial information for affected individuals and their families.
DOLK Gene Glycosylation Disorder Type 1M Genetic Test Cost
The "DOLK Gene Glycosylation Disorder Type 1M Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the DOLK gene, which are responsible for a rare genetic condition known as Congenital Disorders of Glycosylation Type 1m (CDG-1m). This condition affects the body's ability to properly attach sugar molecules to proteins, a process essential for various bodily functions. Symptoms can range from mild to severe and may include developmental delay, skin abnormalities, and problems with the nervous system and internal organs. The test, priced at 4400 AED, involves analyzing the patient's DNA to look for specific mutations in the DOLK gene that are indicative of the disorder. This is crucial for confirming the diagnosis, understanding the disease's progression, and potentially guiding treatment options. Conducted at DNA Labs UAE, the test represents an important step towards personalized medicine, offering hope to families affected by this rare condition by providing them with accurate diagnoses and the possibility of targeted interventions.
RFT1 Gene Glycosylation Disorder Type 1N Genetic Test Cost
The "RFT1 Gene Glycosylation Disorder Type 1N Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RFT1 gene. These mutations can lead to a type of Congenital Disorder of Glycosylation (CDG), specifically Type 1N, which is a rare genetic condition. CDGs are a group of inherited metabolic disorders that affect the glycosylation process, a critical biochemical pathway responsible for the proper function and structure of most proteins and lipids in the body. Type 1N CDG, linked to the RFT1 gene, can manifest in various clinical symptoms, including developmental delay, neurological issues, and other systemic complications. Early and accurate diagnosis through genetic testing is crucial for managing the condition, as it can guide treatment options and help in understanding the prognosis. The test at DNA Labs UAE involves collecting a DNA sample, usually through a blood draw, and analyzing it for specific mutations in the RFT1 gene. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the advanced technology used in detecting these genetic variations. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of their condition, enabling more personalized and effective care.
DPM3 Gene Glycosylation Disorder Type 1O Genetic Test Cost
The DPM3 Gene Glycosylation Disorder Type 1O Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the DPM3 gene. These mutations are responsible for a rare congenital disorder known as Congenital Disorder of Glycosylation Type Io (CDG-Io), which affects the body's ability to properly glycosylate proteins and lipids, essential processes for normal cellular function. Glycosylation disorders like CDG-Io can lead to a wide range of symptoms, including developmental delay, neurological issues, and abnormalities in various organs. Early and accurate diagnosis through genetic testing can be crucial for managing the condition, offering insights into potential treatments, and guiding family planning decisions. The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The process involves collecting a DNA sample from the patient, usually through a blood draw, which is then analyzed for the specific mutations in the DPM3 gene that are indicative of CDG-Io. This test is a vital resource for families seeking answers about this rare genetic disorder and looking for ways to manage its effects.
ALG13 Gene Glycosylation Disorder Type 1S Genetic Test Cost
The "ALG13 Gene Glycosylation Disorder Type 1S Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect abnormalities in the ALG13 gene. This gene plays a critical role in the glycosylation process, a biochemical activity essential for proper protein function and cellular operations. Mutations in the ALG13 gene can lead to Congenital Disorders of Glycosylation (CDG), specifically Type 1S, which is a rare genetic condition that affects multiple systems of the body, including the nervous system, liver, and coagulation processes, leading to a range of symptoms from mild to severe. This genetic test involves analyzing the patient's DNA to identify mutations in the ALG13 gene that are indicative of Type 1S CDG. It is a vital tool for clinicians in diagnosing this condition, enabling them to provide appropriate management and care plans for affected individuals. The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and commitment to providing accurate and timely diagnostic services.